Combined – whole blood and skin fibroblasts - transcriptomic analysis in Psoriatic arthritis.

Study ID Alternative Stable ID Type
EGAS00001006288 Other

Study Description

Whole blood RNA sequencing was performed longitudinally in 27 subjects with PsA at the beginning, one month and six months after treatment and response to therapy was defined at 6 months. As control groups 7 healthy individuals and 9 subjects with rheumatoid arthritis were recruited combined with public RNA-sequencing datasets from patients with psoriasis and systemic lupus erythematous. Differential expression analysis and weighted gene co-expression network analysis were performed to identify gene expression signatures, while deconvolution and flow cytometry to characterize the peripheral blood immune cell profile. RNA sequencing of skin fibroblasts was performed in a subset of affected (n=3) and healthy individuals (n=3) combined with CellChat to identify the blood-skin fibroblasts interaction network.

Study Datasets 1 dataset.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
This dataset contains RNA-sequencing of blood samples from Healthy Controls (n=7), PSA patients (n=27) and RA patients (n=9). It also contains RNA-sequencing data of skin fibroblasts from healthy controls (n=3) and PSA patients (n=3).
NextSeq 500 69

Who archives the data?